Assistant Professor, Medicine, University of Alabama School of Medicine
Nephrology
Dr. Michal Mrug, MD
|
|
Give Review
Michal Mrug, MD practices Nephrology. He attended University of Alabama Medical Center. University of Alabama Medical Center has a rank of 37 in research and a 17 in primary care He has 1 awards "Meaningful Use Stage 1 Certification". Doctor Michal Mrug, MD is a published physician. He published 32 publications, including: 'Angiotensin II stimulates proliferation of normal early erythroid progenitors.' Michal Mrug accepts all Medicare patients.
Publications
- Complement C3 activation in cyst fluid and urine from autosomal dominant polycystic Kidney disease patients.
- Renal macrophages in autosomal recessive polycystic Kidney disease.
- Beware the low HDAC11: males at risk for ischemic Kidney injury.
- Segmentation of Individual Renal Cysts from MR Images in Patients with Autosomal Dominant Polycystic Kidney Disease.
- Proximal Tubule Proliferation Is Insufficient to Induce Rapid Cyst Formation after Cilia Disruption.
- Impact of ultrasound-guided Kidney biopsy simulation on trainee confidence and biopsy outcomes.
- Kidney Injury Accelerates Cystogenesis via Pathways Modulated by Heme Oxygenase and Complement.
- An integrated genetic and physical map of the 650-kb region containing the congenital polycystic Kidney (cpk) locus on mouse chromosome 12.
- Non-anemic homozygous beta(o) thalassemia in an African-American family: association of high fetal hemoglobin levels With beta thalassemia alleles.
- Mapping of mouse alpha 1(XIII) collagen to chromosome 10 and its exclusion as a kd candidate gene.
- Genomic structure of the gene for the human P1 protein (MCM3) and its exclusion as a candidate for autosomal recessive polycystic Kidney disease.
- Genomic organization of the KIAA0057 gene that encodes a TRAM-like protein and its exclusion as a polycystic Kidney and hepatic disease 1 (PKHD1) candidate gene.
- Angiotensin II stimulates proliferation of normal early erythroid progenitors.
- The gene for autosomal dominant craniometaphyseal dysplasia maps to chromosome 5p and is distinct from the growth hormone-receptor gene.
- Identification of highly polymorphic microsatellites in the rhesus macaque Macaca mulatta by cross-species amplification.
- 'Complicated' autosomal dominant familial spastic paraplegia is genetically distinct from 'pure' forms.
- [Polymorphisms in the pseudoautosomal regions of X and Y in DNA diagnosis].
- Overexpression of innate immune response genes in a model of recessive polycystic Kidney disease.
- Not one but two inflammatory bowel Disease susceptibility loci map to chromosome 16.
- Comprehensive human urine standards for comparability and standardization in clinical proteome analysis.
- Potentially modifiable factors affecting the progression of autosomal dominant polycystic Kidney disease.
- Simulation of real-time ultrasound-guided Renal biopsy.
- Renal CD14 expression correlates with the progression of cystic Kidney disease.
- Validation of endogenous internal real-time PCR controls in Renal tissues.
- C3 polymorphisms and outcomes of Renal allografts.
- Blood-borne stem cells differentiate into vascular and cardiac lineages during normal development.
- Kinesin family member 12 is a candidate polycystic Kidney disease modifier in the cpk mouse.
- Angiotensin II receptor type 1 expression in erythroid progenitors: Implications for the pathogenesis of postRenal transplant erythrocytosis.
- Hemothorax and retroperitoneal hematoma after anticoagulation With enoxaparin.
- Refinement of the autosomal recessive polycystic Kidney disease (PKHD1) interval and exclusion of an EF hand-containing gene as a PKHD1 candidate gene.
- Cystin, a novel cilia-associated protein, is disrupted in the cpk mouse model of polycystic Kidney disease.
Procedures Preformed
- Hemodialysis
- Peritoneal Dialysis
Conditions Treated
- Acidosis
- Acute Glomerulonephritis
- Acute Kidney Failure
- Alkalosis
- View All
Doctors Specialties
- Nephrology
Accepted Insurances
- Blue Card PPO
- Dental Blue 100/200/300
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- CoreSource
- Coventry Health Care
- First Health (Coventry Health Care) PPO
- Choice Care PPO
- Medicare MCR
- MultiPlan PPO
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
Awards
- Meaningful Use Stage 1 Certification
Education
-
University of Alabama Medical Center -
University of South Alabama -
Karlovy University Faculty of Medicine
Hospital
-
University of Alabama Hospital -
Birmingham Veterans Affairs Medical Center
Drug Facts
| NPI NUMBER | 1952331332 | |
| NPPES Provider LastName | MRUG | |
| NPPES Provider FirstName | MICHAL | |
| NPPES Provider ZIPCode | 35233 | |
| NPPES Provider State | AL | |
| Specialty Description | Nephrology | |
| Total Claim Count | 82.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1952331332 |
| Last Name Of The Provider | MRUG |
| First Name Of The Provider | MICHAL |
| View All |
Similar Doctors
|
|
Dr. Paul W. Sanders, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Denyse P. Thornley-Brown, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David G. Warnock, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Gerald Norris, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Bruce A. Julian, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
Dr. Richard H. Lyerly, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anupam Agarwal, MD |
|
|
Dr. Mary B. Prendergast, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Edwin A. Rutsky, MD |
|
|
Dr. Eric L. Wallace, MD |
|
|
Dr. Jennifer L. Hughes, MD |
|
|
Dr. Brandi Wynne, MD
This Doctor is OpenDoctor Recommended.
|